Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
02:10pm, Thursday, 01'st Dec 2022 Zacks Investment Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of inco
Moderna Stock: Buy, Sell, or Hold in 2023?
11:30am, Thursday, 01'st Dec 2022 The Motley Fool
Moderna has reached an important turning point.
Will A Pfizer-Partnered Vaccine Help Valneva Stock Buck Its Recent Downtrend?
10:42am, Thursday, 01'st Dec 2022
Valneva stock rose Thursday after it said volunteers who received its Pfizer-partnered Lyme disease shot still had antibodies after six months. The post Will A Pfizer-Partnered Vaccine Help Valneva St
Pfizer Invites Public to Register for Webcast of Pfizer Near-Term Launches + High-Value Pipeline Day
10:00am, Thursday, 01'st Dec 2022
NEW YORK--( BUSINESS WIRE )--Pfizer Inc. (NYSE: PFE) invites investors and the general public to access a live video webcast of its Near-Term Launches + High-Value Pipeline Day on Monday, December 12,
Cosmos Holdings May Be a Long-Term Buy With Short-Term Risk
09:14am, Thursday, 01'st Dec 2022 Investing.comRoivant, Pfizer form company to develop ulcerative colitis treatment
08:20am, Thursday, 01'st Dec 2022
Roivant Sciences ROIV, +4.89% and Pfizer Inc. PFE, +1.29% said Thursday that they created a new company focused on developing and commercializing an ulcerative colitis treatment currently in a Phase 2
Valuation and Dividend Safety Analysis: Pfizer (PFE)
10:39pm, Wednesday, 30'th Nov 2022
Pfizer (NYSE:PFE) is a well-known pharmaceutical company popular with dividend growth and income investors.
7 Most Undervalued Stocks to Buy Now
06:06pm, Wednesday, 30'th Nov 2022
As the market struggles, it's a great time to look for undervalued stocks to buy. There are bargains to be found in the current stock market for investors who have nerves of steel and can stomach the
Why Pfizer Stock Is a Surefire Winner in 2023
03:24pm, Wednesday, 30'th Nov 2022 The Motley Fool
Pfizer's decline seems a bit premature.
Novavax (NVAX) COVID Jab Gets Expanded Label in WHO's EUL
03:20pm, Wednesday, 30'th Nov 2022 Zacks Investment Research
The WHO updates Emergency Use Listing (EUL) for Novavax's (NVAX) COVID-19 vaccine to include its use as a primary series in adolescents and for use as a booster dose in adults.
Why Pfizer Stock Is a Surefire Winner in 2023
10:24am, Wednesday, 30'th Nov 2022
Pfizer's decline seems a bit premature.
Pfizer: COVID-19 May Never End
08:53pm, Tuesday, 29'th Nov 2022
Pfizer's net income was $8,609 million in Q3 2022, up 5.7% year-on-year. The number of Pfizer product candidates continues to grow at a significant pace due to the continued high sales of Paxlovid.
7 Undervalued Biotech Stocks to Buy Before They Boom
08:30pm, Tuesday, 29'th Nov 2022
You'll often hear people say that bear markets are great for finding bargains, and that's true. With the exception of energy, every major sector is in the red for the year.
IMF head joins chorus calling on China to adapt COVID strategy as officials pledge to boost vaccinations among elderly
04:21pm, Tuesday, 29'th Nov 2022 MarketWatch
The head of the International Monetary Fund on Tuesday joined the chorus of people urging China to adopt a more targeted approach to the coronavirus pandemic.
3 Reasons Pfizer Stock Will Crush the Broader Market in 2023
11:00am, Tuesday, 29'th Nov 2022 The Motley Fool
Pfizer's revenue growth is far from over.
